Ethical concerns regarding heterologous COVID-19 vaccine administration

"Ethical concerns regarding heterologous COVID-19 vaccine administration." Human Vaccines & Immunotherapeutics, 20(1), pp.

This article responds to:

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines

Authors’ contribution

SW 50% ideas, writing, analyzing, approval.

VW 50% ideas, supervision, approval.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

There is no new data generated.